Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
The modules that follow are structured to distinguish clearly between preclinical (rodent or in vitro) evidence and the small body of human pilot data
Synergy with Hyaluronic Acid (HA): When co-administered with HA, AOD 9604 demonstrated superior efficacy in reducing lameness and structural damage compared to either agent alone
It works by reducing appetite, increasing feelings of fullness, slowing gastric emptying, boosting insulin release when blood sugar is high, and reducing glucagon secretion
Subcutaneous injection (into fat tissue) is standard for most peptides
Best for initial exploration
doi:10.1093/ajcn/75.4.605
US$ 23.89
US$ 25.70
US$ 24.34
